Hero Image

Cardiac Ejection Fraction 30% - Risks and Next Steps

Seeing “cardiac ejection fraction 30%” on your test report can feel overwhelming.

It means your heart’s main pumping chamber is pushing out far less blood than usual with each beat—but with the right plan, many people stabilize, improve, and live well for years.

Quick answer: Is an ejection fraction of 30% dangerous?

Yes—an ejection fraction (EF) of 30% is a serious finding and typically falls under heart failure with reduced ejection fraction (HFrEF). In practical terms, your heart isn’t meeting the body’s full demand for oxygen-rich blood, which can lead to shortness of breath, swelling, and fatigue. Still, it’s a condition cardiology teams manage every day, and outcomes are far better now than they were even a decade ago.

Compared with the usual EF of about 55–70%, 30% signals a significantly weakened pump. That raises the risk of fluid buildup in the lungs and legs, hospitalizations, and abnormal rhythms. It often calls for multiple medications and sometimes devices—but the number is only part of the story: how you feel, your vital signs, and how quickly treatment starts all shape risk.

The encouraging news: with guideline-directed therapy, cardiac rehab, and careful self-monitoring, many people see symptoms improve—and some even see EF rise over months. Early action matters most.

What ejection fraction really measures

Think of the left ventricle—the heart’s main pump—like a sponge. When it squeezes, not all the blood leaves; EF is simply the percentage that gets ejected with each beat. At 30%, roughly one‑third of the blood in the ventricle is pushed forward and two‑thirds remain.

EF is a percentage of how forcefully the left ventricle squeezes, not the total amount of blood in your body. It’s a snapshot taken at the time of testing, so it can change with treatment or worsening disease. And while EF reflects pumping strength, it doesn’t tell you whether arteries are blocked—that requires different tests.

  • EF measures squeeze, not blockages.
  • It focuses on the left ventricle, the workhorse chamber.
  • It can rise or fall over time as your condition and therapy change.

Normal ranges vs. 30%: where does it fit?

Doctors use general ranges to interpret EF. Typical categories many clinicians reference are:

  • 55–70%: Normal pumping function
  • 41–49%: Mildly reduced
  • 31–40%: Moderately reduced
  • ≤30%: Severely reduced

An EF of 30% sits at the lower edge of these ranges. It often triggers more intensive medication regimens and, depending on your symptoms and heart rhythm, discussions about devices. Remember: symptoms and quality of life matter as much as the number.

For background on EF and heart failure, see overviews from the American Heart Association and types of heart failure.

Common causes of an EF around 30%

Hearts usually weaken for ischemic or non‑ischemic reasons. Ischemic causes involve reduced blood flow to heart muscle—often from coronary artery disease or a prior heart attack that left scar tissue behind. Non‑ischemic causes include conditions that directly injure or overwork the heart muscle.

  • Coronary artery disease or past heart attack (scar tissue lowers squeeze) — learn about CAD at the CDC.
  • Long‑standing high blood pressure that strains and enlarges the heart (high blood pressure basics).
  • Heart valve problems (tight or leaky valves) — overview from the AHA.
  • Myocarditis (viral or inflammatory injury to heart muscle); see myocarditis info.
  • Alcohol or certain chemotherapy drugs (toxic cardiomyopathy).
  • Genetic cardiomyopathies that run in families.
  • Thyroid disease, sleep apnea, or fast heart rhythms that “wear out” the heart over time.

Your care team will look for the root cause because it guides treatment. For example, fixing a tight valve or opening a blocked artery can sometimes improve EF meaningfully.

Symptoms you may notice

Some people with EF 30% feel fine at first; others develop symptoms as the body struggles to keep up. Be alert for:

  • Shortness of breath with activity, at night, or when lying flat
  • Swelling in legs, ankles, feet, or abdomen
  • Fatigue, exercise intolerance, or brain fog
  • Persistent cough or wheeze, especially when lying down
  • Rapid, pounding, or irregular heartbeat (palpitations)
  • Sudden weight gain (e.g., 2–3+ pounds overnight or 5+ in a week)

Call emergency services right away for severe chest pain, fainting, extreme trouble breathing, new confusion, or a rapid heart rhythm that won’t settle. These can signal dangerous complications.

How doctors test and track ejection fraction

The most common test is an echocardiogram—an ultrasound of the heart that shows moving images of the chambers and valves. It’s painless and radiation‑free. Read more from the NHLBI.

When more detail is needed, other tools can help:

  • Cardiac MRI: high‑resolution pictures of heart structure, function, and scar (RadiologyInfo).
  • MUGA scan: a nuclear test that precisely measures EF (MedlinePlus).
  • Coronary angiography/catheterization: checks for blockages if ischemia is suspected.

Expect periodic rechecks—often after medication changes or about 3–6 months into therapy. EF can improve with the right treatment, remain stable, or, if undertreated, decline.

Treatment: how to feel better and raise EF if possible

Care for EF 30% has two goals: improve symptoms and reduce hospitalizations now, and strengthen the heart over time. The backbone is guideline‑directed medical therapy (GDMT)—a combination of medicines proven to help people live longer and feel better. Current guideline summaries are available from professional societies like the AHA/ACC/HFSA.

  • ARNI (sacubitril/valsartan) or ACE inhibitor/ARB: relax blood vessels, lower pressure, and reduce heart stress.
  • Beta‑blocker (e.g., metoprolol succinate, carvedilol, bisoprolol): slows heart rate so the ventricle fills and pumps more efficiently.
  • MRA (spironolactone or eplerenone): blocks harmful hormones and helps prevent scarring.
  • SGLT2 inhibitor (dapagliflozin or empagliflozin): improves outcomes in HFrEF regardless of diabetes; see clinical perspectives from the ACC.
  • Diuretics (e.g., furosemide, torsemide, bumetanide): relieve fluid buildup to ease breathing and swelling.

Some people benefit from devices:

  • ICD (implantable cardioverter‑defibrillator) to prevent sudden death from dangerous rhythms when EF stays ≤35% despite therapy (AHA overview).
  • CRT (cardiac resynchronization therapy) to coordinate heartbeats if the heart’s timing is off (AHA CRT).

Treating the cause is just as important: revascularization for blocked arteries, repairing or replacing faulty valves, addressing sleep apnea, or stopping heart‑toxic substances (e.g., alcohol, certain drugs). Supervised exercise through cardiac rehabilitation is safe and can improve stamina and quality of life.

Daily actions that make a real difference

  • Know your sodium: Many people are advised to keep to about 1,500–2,000 mg sodium/day—check your plan with your clinician (see AHA guidance on daily sodium).
  • Weigh in daily: Same scale, same time of day. Call your clinic if you gain 2–3+ pounds overnight or 5+ in a week.
  • Take meds exactly as prescribed: Don’t stop or change doses without medical advice.
  • Move safely: Ask about cardiac rehab; aim for light, regular activity within your limits.
  • Limit alcohol; avoid tobacco and illicit drugs.
  • Sleep matters: Treat snoring or sleep apnea; good sleep reduces heart strain.
  • Know your “sick day” plan: What to do with diuretics or other meds if you have vomiting, diarrhea, or infection.
  • Stay current on vaccinations per clinician advice to reduce infection‑related stress on the heart.
  • Track symptoms: Keep a simple diary of breathlessness, swelling, heart rate, and blood pressure if advised.

Questions to bring to your next appointment

  • What do you think is the most likely cause of my low EF?
  • Which medications am I on for heart failure—and what dose increases are planned next?
  • When will we recheck my EF and labs (kidney function, potassium, etc.)?
  • Do I qualify for cardiac rehab, an ICD, or CRT?
  • What are my sodium and fluid targets?
  • What symptoms should make me call the clinic vs. go to the ER?
  • Should my family be screened for inherited cardiomyopathy?

Outlook: why there’s room for optimism

EF is not destiny. With modern therapy, people often feel better within weeks; measurable EF gains, if they occur, usually take 3–6 months, sometimes longer. Even if the percentage stays around 30%, symptom relief and fewer hospital visits are meaningful wins.

If EF remains ≤35% after optimized therapy, ask about referral to a center with advanced heart‑failure expertise (learn more). These teams can evaluate additional options, from specialized devices to clinical trials.

Disclaimer: This article is for general information and is not a substitute for professional medical advice. Always speak with your clinician about your specific situation, medications, and test results.